Use of 18F-FDG PET/MRI as an Initial Staging Procedure for Nasopharyngeal Carcinoma

被引:1
作者
Cao, Caineng [1 ]
Fang, Yuting [1 ]
Yu, Bocheng [2 ]
Xu, Yuanfan [3 ]
Qiang, Mengyun [1 ]
Tao, Changjuan [1 ]
Huang, Shuang [1 ]
Chen, Xiaozhong [1 ,4 ]
机构
[1] Univ Chinese Acad Sci, Zhejiang Canc Hosp, Inst Basic Med & Canc IBMC, Chinese Acad Sci,Dept Radiat Oncol,Canc Hosp,Key L, Hangzhou, Zhejiang, Peoples R China
[2] Nanjing Univ Chinese Med, Sch Informat Technol, Nanjing, Jiangsu, Peoples R China
[3] Hangzhou Universal Med Imagine Diagnost Ctr, Hangzhou, Zhejiang, Peoples R China
[4] 1 East Banshan Rd, Hangzhou 310022, Zhejiang, Peoples R China
关键词
PET; nasopharyngeal carcinoma; cost-effectiveness analysis; tumor staging; BREAST-CANCER; METASTASIS; PET/CT;
D O I
10.1002/jmri.28842
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: Compared with the conventional work-up (CWU) including computed tomography (CT) of the chest and abdomen, MRI of the head and neck, and skeletal scintigraphy, positron emission tomography (PET)/MRI might improve diagnostic accuracy, shorten the work-up time, and reduce false-positive (FP) findings in patients with nasopharyngeal carcinoma (NPC). However, evidence of cost-effectiveness is needed for the adoption of PET/MRI for the initial staging in NPC.Purpose: To evaluate the cost-effectiveness and clinical value of PET/MRI as an initial staging procedure for NPC.Study Type: Retrospective cohort cost effectiveness study.Subjects: Three hundred forty-three patients with a median age of 51 (13-81) years underwent PET/MRI before treatment (the PET/MRI group) and the remaining 677 patients with a median age of 55 (15-95) years only underwent CWU (the CWU group). There were 80 (23.3%) females and 193 (28.5%) females in the PET/MRI and CWU groups, respectively.Field Strength/Sequence: 3-T integrated PET/MRI system, diffusion-weighted echo-planar imaging (b = 0 and 1000 s/ mm(2)) and [18F] fluorodeoxyglucose PET.Assessment: The primary end point was the FP rate. Costs were determined as issued in 2021 by the Medical Insurance Administration Bureau of Zhejiang, China.Statistical Tests: Incremental cost effectiveness ratio (ICER) measured cost of using PET/MRI per percent of patients who avoided a FP. A P-value <0.05 was considered statistically significant.Results: For the whole group, the de novo metastatic disease rate was 5.2% (53/1020). A total of 187 patients with FP results were observed. Significantly more patients with FP results were observed in the CWU group compared to the PET/MRI group (25.6% vs. 4.1%). The ICER was $54 for each percent of patients avoiding a FP finding.Data Conclusion: Compared with CWU, PET/MRI may reduce the FP risk. Furthermore, PET/MRI may be cost-effective as an initial staging procedure for NPC.
引用
收藏
页码:922 / 928
页数:7
相关论文
共 24 条
[1]  
Amin MB, 2017, AJCC cancer staging manual, V8th
[2]  
[Anonymous], US
[3]   18F-Choline PET/mpMRI for Detection of Clinically Significant Prostate Cancer: Part 2. Cost-Effectiveness Analysis [J].
Barnett, Christine L. ;
Davenport, Matthew S. ;
Montgomery, Jeffrey S. ;
Kunju, Lakshmi Priya ;
Denton, Brian T. ;
Piert, Morand .
JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (12) :1705-1712
[4]   Feasibility of multiparametric imaging with PET/MR in nasopharyngeal carcinoma: A pilot study [J].
Cao, Caineng ;
Yang, Pengfei ;
Xu, Yuanfan ;
Niu, Tianye ;
Hu, Qiaoying ;
Chen, Xiaozhong .
ORAL ONCOLOGY, 2019, 93 :91-95
[5]   Paranasal Sinus Invasion in Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy [J].
Cao, Caineng ;
Jiang, Feng ;
Jin, Qifeng ;
Jin, Ting ;
Huang, Shuang ;
Hu, Qiaoying ;
Chen, Yuanyuan ;
Piao, Yongfeng ;
Hua, Yonghong ;
Feng, Xinglai ;
Chen, Xiaozhong .
CANCER RESEARCH AND TREATMENT, 2019, 51 (01) :73-79
[6]   Locoregional extension and patterns of failure for nasopharyngeal carcinoma with intracranial extension [J].
Cao, Caineng ;
Jiang, Feng ;
Jin, Qifeng ;
Jin, Ting ;
Huang, Shuang ;
Hu, Qiaoying ;
Chen, Yuanyuan ;
Piao, Yongfeng ;
Hua, Yonghong ;
Feng, Xinglai ;
Chen, Xiaozhong .
ORAL ONCOLOGY, 2018, 79 :27-32
[7]   Comparison of CE-FDG-PET/CT with CE-FDG-PET/MR in the evaluation of osseous metastases in breast cancer patients [J].
Catalano, O. A. ;
Nicolai, E. ;
Rosen, B. R. ;
Luongo, A. ;
Catalano, M. ;
Iannace, C. ;
Guimaraes, A. ;
Vangel, M. G. ;
Mahmood, U. ;
Soricelli, A. ;
Salvatore, M. .
BRITISH JOURNAL OF CANCER, 2015, 112 (09) :1452-1460
[8]   Clinical utility of simultaneous whole-body 18F-FDG PET/MRI as a single-step imaging modality in the staging of primary nasopharyngeal carcinoma [J].
Chan, Sheng-Chieh ;
Yeh, Chih-Hua ;
Yen, Tzu-Chen ;
Ng, Shu-Hang ;
Chang, Joseph Tung-Chieh ;
Lin, Chien-Yu ;
Yen-Ming, Tsang ;
Fan, Kang-Hsing ;
Huang, Bing-Shen ;
Hsu, Cheng-Lung ;
Chang, Kai-Ping ;
Wang, Hung-Ming ;
Liao, Chun-Ta .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (08) :1297-1308
[9]   Exploratory cost-effectiveness analysis of 68Gallium-PSMA PET/MRI-based imaging in patients with biochemical recurrence of prostate cancer [J].
Gordon, Louisa G. ;
Elliott, Thomas M. ;
Joshi, Andre ;
Williams, Elizabeth D. ;
Vela, Ian .
CLINICAL & EXPERIMENTAL METASTASIS, 2020, 37 (02) :305-312
[10]   Mortality due to cancer treatment delay: systematic review and meta-analysis [J].
Hanna, Timothy P. ;
King, Will D. ;
Thibodeau, Stephane ;
Jalink, Matthew ;
Paulin, Gregory A. ;
Harvey-Jones, Elizabeth ;
O'Sullivan, Dylan E. ;
Booth, Christopher M. ;
Sullivan, Richard ;
Aggarwal, Ajay .
BMJ-BRITISH MEDICAL JOURNAL, 2020, 371 :m4087